Keith Pardee

Canada Research Chair in Synthetic Biology and Human Health

Tier 2 - 2016-04-01
Renewed: 2021-04-01
University of Toronto
Canadian Institutes of Health Research


Research involves

Combining synthetic biology with molecular engineering and electronics in order to build sterile and abiotic biomolecular devices.

Research relevance

These low-cost technologies will create new tools for research and extend laboratory capabilities out into the world as portable diagnostics and therapeutic manufacturing.

Research summary

Genomics research has set the stage for what many believe will be the century of biology—and Dr. Keith Pardee, Canada Research Chair in Synthetic Biology and Human Health, is dedicated to developing the technologies we will need to make it happen.Pardee has led patient trials for synthetic biology-based technologies, including one for Zika virus diagnostics and another for COVID-19 diagnostics. Now, he and his research team are focusing on molecular tools that have applications in health care and national security, including the first direct gene-circuit-to-electronic interface and a series of other upcoming technologies. Ultimately, they hope to usher in the era of synthetic biology using the power of nature to solve complex problems in medicine.